SBI Securities »

Pharmacyte Biotech shares owned by SBI Securities

Quarter-by-quarter ownership of Pharmacyte Biotech (PMCB) shares owned by SBI Securities from 13F filings

Historical chart of SBI Securities investment in Pharmacyte Biotech

Tip: Access up to 7 years of quarterly data

All positions including Pharmacyte Biotech held by SBI Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pharmacyte Biotech by SBI Securities

Quarter filed Position value Share count Share price at filing
2026-03-31 $2 3 0.67

More positions owned by SBI Securities

NVIDIA Corporation (NVDA)
Vanguard S&P 500 ETF Etf (VOO)
Vanguard Total Stock Market ETF Etf (VTI)
Apple (AAPL)
Invesco QQQ Trust Series 1 ETF Etf (QQQ)
Vanguard Total World Stock ETF Etf (VT)
Tesla Motors (TSLA)
Alphabet Inc Class A cs (GOOGL)
Vanguard High Dividend Yield ETF Etf (VYM)
Amazon (AMZN)
Palantir Technologies (PLTR)
Microsoft Corporation (MSFT)
ST SPDR Portfolio S&P500HighDividend ETF Etf (SPYD)
SPDR Gold MiniShares Trust Etf (GLDM)
Alphabet Inc Class C cs (GOOG)

View all positions for SBI Securities

Top funds holding Pharmacyte Biotech

Citadel Advisors
Geode Capital Management
Sabby Management
Renaissance Technologies
Vanguard Group
Vanguard Capital Management
Northern Trust
Schonfeld Strategic Advisors
Simplex Trading
Hrt Financial
XTX Topco
Vanguard Fiduciary Trust
Equitec Proprietary Markets
Two Sigma Securities
Jane Street

View all funds holding Pharmacyte Biotech